Phone app aims to ease cancer treatment burden
NCT ID NCT05425550
Summary
This study tested whether a smartphone app could help people with HER2-positive breast cancer better manage side effects during chemotherapy. About 196 participants were randomly assigned to either use the app alongside their normal treatment or receive normal treatment alone. The app allowed patients to track symptoms and share them with their doctor, with the goal of reducing severe side effects and unplanned hospital visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seespital Horgen-Onkologie
Horgen, 8810, Switzerland
Conditions
Explore the condition pages connected to this study.